Black Diamond Therapeutic...
(BDTX)
undefined
undefined%
At close: undefined
2.56
0.99%
Pre-market Dec 16, 2024, 04:14 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -82.44M | -91.17M | -125.60M | -67.25M | -35.26M | -8.93M | -4.60M |
| Depreciation & Amortization | 437.00K | 508.00K | 205.00K | 52.00K | 47.00K | 44.00K | 24.00K |
| Stock-Based Compensation | 9.60M | 12.20M | 14.04M | 7.76M | 3.64M | 64.00K | 5.00K |
| Other Working Capital | 3.09M | -7.67M | 5.45M | 3.97M | -991.00K | 90.00K | 1.80M |
| Other Non-Cash Items | 2.00M | 3.28M | 2.01M | 524.00K | 6.43M | 15.00K | 66.00K |
| Deferred Income Tax | - | - | 2.18M | 1.73M | - | - | 412.00K |
| Change in Working Capital | 3.69M | -9.90M | 7.02M | 5.04M | 463.00K | 354.00K | 1.74M |
| Operating Cash Flow | -66.72M | -85.08M | -100.15M | -52.15M | -24.67M | -8.45M | -2.35M |
| Capital Expenditures | -33.00K | -192.00K | -2.71M | -142.00K | -21.00K | -76.00K | -77.00K |
| Acquisitions | - | 9.00K | 2.70M | 118.00K | - | - | - |
| Purchase of Investments | -61.89M | -60.14M | -49.51M | -372.48M | - | - | - |
| Sales Maturities Of Investments | 78.17M | 113.69M | 182.83M | 90.93M | - | - | - |
| Other Investing Acitivies | 95.00K | 53.56K | -2.70M | -118.00K | -21.00K | - | - |
| Investing Cash Flow | 16.35M | 53.37M | 130.61M | -281.69M | -21.00K | -76.00K | -77.00K |
| Debt Repayment | - | - | - | - | - | - | -50.00K |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 82.00K | 177.00K | 729.00K | 1.10M | 127.76M | 52.31M | 19.95M |
| Financial Cash Flow | 71.93M | 177.00K | 729.00K | 214.94M | 127.76M | 52.31M | 9.97M |
| Net Cash Flow | 21.56M | -31.54M | 31.19M | -118.89M | 103.06M | 43.78M | 7.55M |
| Free Cash Flow | -66.75M | -85.27M | -102.86M | -52.29M | -24.70M | -8.53M | -2.43M |